Clinical Trial Update: TMS for Cognitive Decline in Aging and Preclinical AD [NA]

View source ↗

Summary

This Massachusetts General Hospital-sponsored clinical trial is evaluating transcranial magnetic stimulation (TMS) for cognitive decline in aging and preclinica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prodromal Alzheimer's Disease, Preclinical Alzheimer's Disease | NA | Status: RECRUITING